Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Effects by periodontitis on pristane-induced arthritis in rats.

Eriksson K, Lönnblom E, Tour G, Kats A, Mydel P, Georgsson P, Hultgren C, Kharlamova N, Norin U, Jönsson J, Lundmark A, Hellvard A, Lundberg K, Jansson L, Holmdahl R, Yucel-Lindberg T.

J Transl Med. 2016 Nov 3;14(1):311.

2.

Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes.

Nyström J, Chen A, Frelin L, Ahlén G, Koh S, Brass A, Peterson DL, Fons M, Milich DR, Hultgren C, Sällberg M.

J Infect Dis. 2010 Jun 15;201(12):1867-79. doi: 10.1086/652808.

PMID:
20446851
3.

Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.

Nyström J, Cardell K, Björnsdottir TB, Fryden A, Hultgren C, Sällberg M.

Vaccine. 2008 Nov 5;26(47):5967-72. doi: 10.1016/j.vaccine.2008.08.054. Epub 2008 Sep 17.

PMID:
18804140
4.

Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.

Watts NR, Cardone G, Vethanayagam JG, Cheng N, Hultgren C, Stahl SJ, Steven AC, Sällberg M, Wingfield PT.

J Mol Biol. 2008 Jun 20;379(5):1119-29. doi: 10.1016/j.jmb.2008.04.009. Epub 2008 Apr 9.

5.

Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.

Fischler B, Nyström J, Björnsdottir T, Lindh G, Hultgren C.

J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):75-83.

PMID:
17592368
6.

Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C.

Desombere I, Van Vlierberghe H, Weiland O, Hultgren C, Sällberg M, Quiroga J, Carreño V, Leroux-Roels G.

J Med Virol. 2007 Jun;79(6):701-13.

PMID:
17457916
7.

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.

Frelin L, Brenndörfer ED, Ahlén G, Weiland M, Hultgren C, Alheim M, Glaumann H, Rozell B, Milich DR, Bode JG, Sällberg M.

Gut. 2006 Oct;55(10):1475-83. Epub 2006 Mar 9.

8.

In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes.

Ahlen G, Nystrom J, Pult I, Frelin L, Hultgren C, Sallberg M.

J Infect Dis. 2005 Dec 15;192(12):2112-6. Epub 2005 Nov 4.

PMID:
16288375
9.

Changing prevalence of hepatitis B virus genotypes in Iceland.

Björnsdottir TB, Stanzeit B, Sällberg M, Löve A, Hultgren C.

J Med Virol. 2005 Dec;77(4):481-5.

PMID:
16254980
10.

Predictive factors and virological response to interferon treatment in children with chronic hepatitis B.

Söderström A, Lindh M, Ekholm K, Conradi N, Horal P, Krantz M, Hultgren C, Norkrans G.

Scand J Infect Dis. 2005;37(1):40-7.

PMID:
15764189
11.

GB virus C coinfection and vertical transmission in HIV-infected mothers before the introduction of antiretroviral prophylaxis.

Barqasho B, Navér L, Bohlin AB, Lindgren S, Hultgren C, Birk M.

HIV Med. 2004 Nov;5(6):427-30.

12.

Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.

Hultgren C, Desombere I, Leroux-Roels G, Quiroga JA, Carreno V, Nilsson B, Weiland O, Sällberg M.

J Hepatol. 2004 Jun;40(6):971-8.

PMID:
15158338
13.

Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent.

Lazdina U, Alheim M, Nyström J, Hultgren C, Borisova G, Sominskaya I, Pumpens P, Peterson DL, Milich DR, Sällberg M.

J Gen Virol. 2003 Jan;84(Pt 1):139-46.

PMID:
12533710
14.

Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.

Lazdina U, Hultgren C, Frelin L, Chen M, Lodin K, Weiland O, Leroux-Roels G, Quiroga JA, Peterson DL, Milich DR, Sällberg M.

J Gen Virol. 2001 Jun;82(Pt 6):1299-308.

PMID:
11369873
15.

T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model.

de Carvalho Nicacio C, Sällberg M, Hultgren C, Lundkvist A.

J Gen Virol. 2001 Jan;82(Pt 1):129-38.

PMID:
11125166
16.

Humoral and cellular immune responses to the GB virus C/hepatitis G virus envelope 2 protein.

Lazdina U, Hultgren C, Chen M, Fischler B, Weiland O, Mushahwar IK, Sällberg M.

J Med Virol. 2000 Nov;62(3):334-44.

PMID:
11055243
17.
18.

Analysis of GB virus C markers in families over three generations.

Chen M, Fischler B, Hultgren C, Halasz R, Nemeth A, Sällberg M.

J Clin Microbiol. 1999 Dec;37(12):4153-5.

19.

Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products.

Halasz R, Barkholt L, Lara C, Hultgren C, Ando Y, Broomé U, Fischler B, Nemeth A, Ericzon BG, Sönnerborg A, Sällberg M.

Gut. 1999 Feb;44(2):274-8. Erratum in: Gut 1999 Jun;44(6):898.

20.

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.

Hultgren C, Milich DR, Weiland O, Sällberg M.

J Gen Virol. 1998 Oct;79 ( Pt 10):2381-91.

PMID:
9780043
21.

Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen.

Sällberg M, Hughes J, Javadian A, Ronlov G, Hultgren C, Townsend K, Anderson CG, O'Dea J, Alfonso J, Eason R, Murthy KK, Jolly DJ, Chang SM, Mento SJ, Milich D, Lee WT.

Hum Gene Ther. 1998 Aug 10;9(12):1719-29.

PMID:
9721082
22.

Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses.

Visco-Comandini U, Hultgren C, Broström C, Birk M, Kim S, Sällberg M.

Clin Diagn Lab Immunol. 1998 Jul;5(4):463-6.

23.

Mutations and deletions within the hepatitis B virus core antigen and locations of B cell recognition sites.

Sällberg M, Hultgren C.

J Infect Dis. 1998 Jan;177(1):264-5. No abstract available.

PMID:
9419204
24.
26.

Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation.

Tsunetsugu-Yokota Y, Akagawa K, Kimoto H, Suzuki K, Iwasaki M, Yasuda S, Häusser G, Hultgren C, Meyerhans A, Takemori T.

J Virol. 1995 Jul;69(7):4544-7.

27.

Infection of cultured immature dendritic cells with human immunodeficiency virus type 1.

Häusser GA, Hultgren C, Akagawa K, Tsunetsugu-Yokota Y, Meyerhans A.

Adv Exp Med Biol. 1995;378:477-9.

PMID:
8526122
28.

Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools.

Meyerhans A, Vartanian JP, Hultgren C, Plikat U, Karlsson A, Wang L, Eriksson S, Wain-Hobson S.

J Virol. 1994 Jan;68(1):535-40.

29.

Site-selective oxygen-isotope substitution in YBa2Cu3O7- delta.

Morris DE, Markelz AG, Wei JY, Hultgren CT, Nickel JH, Hamilton JC, McCarty KF.

Phys Rev B Condens Matter. 1991 Nov 1;44(17):9556-9561. No abstract available.

PMID:
9998941
30.

Eight new high-temperature superconductors with the 1:2:4 structure.

Morris DE, Nickel JH, Wei JY, Asmar NG, Scott JS, Scheven UM, Hultgren CT, Markelz AG, Post JE, Heaney PJ, Veblen DR, Hazen RM.

Phys Rev B Condens Matter. 1989 Apr 1;39(10):7347-7350. No abstract available.

PMID:
9947406
31.

Oxygen concentration effect on Tc of the Bi-Ca-Sr-Cu-O superconductor.

Morris DE, Hultgren CT, Markelz AM, Wei JY, Asmar NG, Nickel JH.

Phys Rev B Condens Matter. 1989 Apr 1;39(10):6612-6614. No abstract available.

PMID:
9947302

Supplemental Content

Loading ...
Support Center